Position in OGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$44,232,820
+$24,673,796 QoQ
Shares Held
3,266,826
+0.0% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#16
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 81%
Shared 15%
None 4%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $19,386,650,383 across 15 Drug Manufacturers - General names. OGN ranks #14 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,003,417 | $4,801,818,850 | |
| 2 | JNJ |
Johnson & Johnson
|
15,385,556 | $3,907,469,656 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,486,486 | $2,247,013,450 | |
| 4 | ABBV |
AbbVie Inc.
|
7,236,861 | $1,821,083,699 | |
| 5 | NVS |
Novartis AG
|
8,117,586 | $1,272,188,077 | |
| 6 | AMGN |
Amgen Inc
|
3,413,981 | $1,236,270,798 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,691,951 | $1,134,650,214 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,899,794 | $998,059,971 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,232,820 | 3,266,826 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $19,559,024 | 3,265,280 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $24,264,282 | 3,384,140 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $39,404,391 | 3,689,550 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $44,798,176 | 4,627,911 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $62,071,524 | 4,168,672 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $49,003,365 | 3,284,408 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $50,794,298 | 2,655,217 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $49,843,838 | 2,407,915 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $36,560,339 | 1,944,699 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $26,366,102 | 1,828,440 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $35,305,794 | 2,033,744 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $29,403,070 | 1,412,930 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $35,041,457 | 1,489,858 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $40,117,811 | 1,436,370 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $34,740,363 | 1,484,631 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $50,599,315 | 1,499,239 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $52,329,331 | 1,498,120 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $45,842,505 | 1,505,501 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $53,034,742 | 1,617,406 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $29,923,720 | 988,887 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||